A new study from the Information Technology & Innovation Foundation, “The Bayh-Dole Act’s Vital Importance to the U.S. Life-Sciences Innovation System,” is caught-up in the debate over drug price controls. Specifically, the issue is over something called “march-in rights.” According to the author of this article in IPWatchdog, some are arguing that the law authorizes the government to license competitors if a resulting product isn’t “reasonably priced.”
East Tennessee Economic Council "After Hours"
- Ts117, 701 Scarboro Road, Oak Ridge
- Apr 24 2019
Webinar of DoD SBIR and STTR Program
- Apr 25 2019
"All American Makers" Knoxville Edition
- Pellissippi State Community College’s Hardin Valley Campus
- May 02 2019
Startup Tri-Cities "Pitches and Pints"
- VENUE at the King’s Centre, Johnson City
- May 09 2019
Tennessee Valley Corridor National Summit
- UT Chattanooga
- May 29 2019